Study suggests limits on opioid dosage may not reduce overdoses

09/17/2013 | Medscape (free registration)

Restricting daily morphine dosages to 100 mg may not be an effective strategy to reduce overdoses, according to Purdue Pharma research released at PAINWeek 2013. The study, which cited age, sedative use and lack of a recent opioid prescription as factors in overdose risk, followed recommendations from Physicians for Rational Opioid Prescribing that included limiting doses for noncancer pain.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA